Cipla
Neel Jobanputra, CA, ACCA, currently serves as FP&A Lead for North America at Cipla, having progressed through various finance roles including Business Finance Partner for India's Vitalis cluster and Cluster Finance Manager for both Cardiology and Diabetes and Urology and Neuropsychiatry. Neel's experience prior to Cipla includes positions at PwC India, where responsibilities encompassed corporate and international tax advisory as an Assistant Manager, and prior roles at D. R. Doshi & Co. and JMP Advisors Private Limited as an Article Assistant, focusing on direct and indirect taxation. Neel holds a Chartered Certified Accountant qualification from ACCA and a Chartered Accountancy degree from The Institute of Chartered Accountants of India, complemented by a Bachelor of Commerce from R A Podar College of Commerce & Economics.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.